EMEA-002873-PIP01-20 - paediatric investigation plan

Live-attenuated La Reunion strain of chikungunya virus (VLA1553)

Key facts

• Active Substance:
  Live-attenuated La Reunion strain of chikungunya virus (VLA1553)
• Therapeutic area:
  Vaccines
• Decision number:
  P/0457/2021
• PIP number:
  EMEA-002873-PIP01-20
• Pharmaceutical form(s):
  Powder and solvent for suspension for injection
• Condition(s) / indication(s):
  Prevention of chikungunya disease
• Route(s) of administration:
  Intramuscular use
• Contact for public enquiries:

  Valneva Austria GmbH

  E-mail: [e-mail]; Tel. [phone]

• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  29/10/2021

Decision

P/0457/2021 : EMA decision of 29 October 2021 on the agreement of a paediatric investigation plan and on the granting of a deferral for liveattenuated La Reunion strain of chikungunya virus (VLA1553) (EMEA-002873-PIP01-20)

Reference Number: EMA/582972/2021